# A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults

> **NCT00752687** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 100 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** ABT-072
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00752687
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-05
- **Final completion:** —
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752687, "A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00752687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*